CELLDEX THERAPEUTICS INC NEW - COM (CLDX) Institutional Ownership

CUSIP: 15117B103

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2023

Type / Class
Equity / COM
Symbol
CLDX on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$2,000 0
2023 Q3 86 $2,000 +$2,000 $23.26 1
2020 Q3 0 $0 -$4,118,000 0
2020 Q2 316,846 $4,118,000 -$1,350,864 $13.00 2
2020 Q1 420,846 $563,000 $1.34 1
2019 Q4 420,846 $708,000 $1.68 1
2019 Q3 420,846 $896,000 $2.13 1
2019 Q2 420,846 $1,127,000 $2.68 1
2019 Q1 420,846 $2,071,000 -$37,813,237 $4.92 1
2018 Q4 50,935,481 $10,079,985 -$1,170,208 $0.20 61
2018 Q3 47,915,892 $21,609,810 -$3,127,821 $0.45 77
2018 Q2 54,402,743 $27,392,430 -$42,858,522 $0.50 89
2018 Q1 73,574,718 $171,419,210 +$15,161,544 $2.33 123
2017 Q4 78,364,237 $222,589,523 +$19,711,344 $2.84 129
2017 Q3 71,335,764 $204,016,886 -$6,376,170 $2.86 125
2017 Q2 73,890,230 $182,511,997 -$22,290,534 $2.47 125
2017 Q1 81,799,533 $295,277,280 +$25,361,577 $3.61 133
2016 Q4 82,661,737 $292,631,929 +$44,238,592 $3.54 138
2016 Q3 69,756,748 $281,693,259 -$41,935,150 $4.04 133
2016 Q2 79,254,129 $347,933,697 -$24,852,152 $4.39 138
2016 Q1 84,927,625 $320,985,942 -$74,271,269 $3.78 137
2015 Q4 88,360,453 $1,385,502,991 +$33,691,495 $15.68 166
2015 Q3 86,956,355 $916,510,248 -$58,242,771 $10.54 157
2015 Q2 86,637,747 $2,185,000,511 -$25,013,337 $25.22 184
2015 Q1 87,387,588 $2,433,954,441 +$175,704,195 $27.87 193
2014 Q4 80,876,778 $1,476,031,275 +$52,536,647 $18.25 162
2014 Q3 79,314,318 $1,027,918,770 -$10,435,700 $12.96 143
2014 Q2 79,631,111 $1,299,479,761 +$23,208,229 $16.32 129
2014 Q1 77,936,557 $1,376,701,988 +$27,697,015 $17.67 154